These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 7981193)
1. Hyperlipidemia accelerates allograft arteriosclerosis (chronic rejection) in the rat. Räisänen-Sokolowski A; Tilly-Kiesi M; Ustinov J; Mennander A; Paavonen T; Tikkanen MJ; Häyry P Arterioscler Thromb; 1994 Dec; 14(12):2032-42. PubMed ID: 7981193 [TBL] [Abstract][Full Text] [Related]
2. Chronic rejection in rat aortic allografts. IV. Effect of hypercholesterolemia in allograft arteriosclerosis. Mennander A; Tikkanen MJ; Räisänen-Sokolowski A; Paavonen T; Ustinov J; Häyry P J Heart Lung Transplant; 1993; 12(1 Pt 1):123-31; discussion 131-2. PubMed ID: 8443189 [TBL] [Abstract][Full Text] [Related]
3. Hyperlipidemia enhances chronic rejection in experimental rat model. Tilly-Kiesi M; Räisänen-Sokolowski A; Ustinov J; Myllärniemi M; Tikkanen MJ; Häyry P Transplant Proc; 1995 Feb; 27(1):582. PubMed ID: 7879107 [No Abstract] [Full Text] [Related]
4. Reversibility of allograft arteriosclerosis after retransplantation to donor strain. Mennander A; Häyry P Transplantation; 1996 Aug; 62(4):526-9. PubMed ID: 8781620 [TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus infection enhances mRNA expression of platelet-derived growth factor-BB and transforming growth factor-beta 1 in rat aortic allografts. Possible mechanism for cytomegalovirus-enhanced graft arteriosclerosis. Lemström KB; Aho PT; Bruggeman CA; Häyry PJ Arterioscler Thromb; 1994 Dec; 14(12):2043-52. PubMed ID: 7981194 [TBL] [Abstract][Full Text] [Related]
6. Triple drug immunosuppression significantly reduces aortic allograft arteriosclerosis in the rat. Lemström KB; Räisänen-Sokolowski AK; Häyry PJ; Koskinen PK Arterioscler Thromb Vasc Biol; 1996 Apr; 16(4):553-64. PubMed ID: 8624778 [TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus infection-enhanced allograft arteriosclerosis is prevented by DHPG prophylaxis in the rat. Lemström KB; Bruning JH; Bruggeman CA; Koskinen PK; Aho PT; Yilmaz S; Lautenschlager IT; Häyry PJ Circulation; 1994 Oct; 90(4):1969-78. PubMed ID: 7923687 [TBL] [Abstract][Full Text] [Related]
8. Effect of mycophenolate mofetil on allograft arteriosclerosis (chronic rejection). Räisänen-Sokolowski A; Myllärniemi M; Häyry P Transplant Proc; 1994 Dec; 26(6):3225. PubMed ID: 7998125 [No Abstract] [Full Text] [Related]
9. Somatostatin analog lanreotide inhibits myocyte replication and several growth factors in allograft arteriosclerosis. Häyry P; Räisänen A; Ustinov J; Mennander A; Paavonen T FASEB J; 1993 Aug; 7(11):1055-60. PubMed ID: 8370476 [TBL] [Abstract][Full Text] [Related]
10. Partial inhibition of allograft arteriosclerosis (chronic rejection) by 15-deoxyspergualin. Räisänen-Sokolowski A; Yilmaz S; Tufveson G; Häyry P Transplantation; 1994 Jun; 57(12):1772-7. PubMed ID: 8016883 [TBL] [Abstract][Full Text] [Related]
11. Rat aortic allografts: an experimental model for chronic transplant arteriosclerosis. Häyry P; Mennander A; Tiisala S; Halttunen J; Yilmaz S; Paavonen T Transplant Proc; 1991 Feb; 23(1 Pt 1):611-2. PubMed ID: 1990624 [No Abstract] [Full Text] [Related]
12. Mechanism of action of 15-deoxyspergualin in allograft arteriosclerosis in rat aortic transplants. Räisänen-Sokolowski A; Aho P; Tufveson G; Häyry P Transplant Proc; 1994 Dec; 26(6):3224. PubMed ID: 7998124 [No Abstract] [Full Text] [Related]
13. Chronic rejection in the rat aortic allograft. V. Mechanism of the angiopeptin (BIM23014C) effect on the generation of allograft arteriosclerosis. Mennander A; Räisänen A; Paavonen T; Häyry P Transplantation; 1993 Jan; 55(1):124-8. PubMed ID: 8420036 [TBL] [Abstract][Full Text] [Related]
14. Cyclosporine-induced endothelialitis and accelerated arteriosclerosis in chronic allograft rejection. Mennander A; Paavonen T; Häyry P Transplant Proc; 1992 Feb; 24(1):341. PubMed ID: 1539306 [No Abstract] [Full Text] [Related]
15. A vitamin D analog, MC1288, inhibits adventitial inflammation and suppresses intimal lesions in rat aortic allografts. Räisänen-Sokolowski AK; Pakkala IS; Samila SP; Binderup L; Häyry PJ; Pakkala ST Transplantation; 1997 Apr; 63(7):936-41. PubMed ID: 9112343 [TBL] [Abstract][Full Text] [Related]
16. Role of thromboxane in the generation of allograft arteriosclerosis in chronic rejection. Häyry P; Mennander A; Paavonen T; Räisänen A; Ustinov J Transplant Proc; 1993 Feb; 25(1 Pt 1):603-4. PubMed ID: 8438433 [No Abstract] [Full Text] [Related]